The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-amino-5-(1-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)pyridin-3-yl)-N-cyclopropyl-3-methoxy-N-methylbenzenesulfonamide ID: ALA4865313
PubChem CID: 122588306
Max Phase: Preclinical
Molecular Formula: C25H26N4O4S
Molecular Weight: 478.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(S(=O)(=O)N(C)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1
Standard InChI: InChI=1S/C25H26N4O4S/c1-29(18-4-5-18)34(31,32)19-6-8-20(23(13-19)33-2)17-12-22(24(26)28-14-17)15-3-7-21-16(11-15)9-10-27-25(21)30/h3,6-8,11-14,18H,4-5,9-10H2,1-2H3,(H2,26,28)(H,27,30)
Standard InChI Key: NEYLNBVCALXARL-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
12.9471 -3.1738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6694 -3.5824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9636 -4.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9471 -2.3690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6776 -4.4079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2455 -3.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2455 -4.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4054 -9.3674 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.6962 -9.7805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7014 -10.6018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9818 -9.3765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5674 -8.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1593 -9.3873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1198 -9.7714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3977 -10.1860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4018 -8.5434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4060 -4.4368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4018 -6.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1158 -4.8454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6961 -7.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8298 -4.4368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8298 -3.6113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7002 -5.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5439 -3.1986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4060 -3.6155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4101 -6.9007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5480 -4.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7002 -4.8454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6919 -8.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1158 -5.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1176 -7.3036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1241 -8.1141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9902 -6.8976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9938 -6.0804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 3 1 0
6 1 1 0
5 2 1 0
3 5 1 0
1 4 2 0
2 1 1 0
16 8 1 0
8 9 1 0
9 10 1 0
9 11 1 0
12 11 1 0
13 12 1 0
11 13 1 0
8 14 2 0
8 15 2 0
29 16 2 0
28 17 1 0
27 7 1 0
18 23 1 0
19 21 1 0
23 28 2 0
20 29 1 0
6 24 1 0
32 16 1 0
24 22 2 0
17 19 2 0
17 25 1 0
22 21 1 0
26 20 2 0
30 18 2 0
26 18 1 0
31 26 1 0
19 30 1 0
21 27 2 0
6 7 2 0
31 32 2 0
20 33 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 478.57Molecular Weight (Monoisotopic): 478.1675AlogP: 3.08#Rotatable Bonds: 6Polar Surface Area: 114.62Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.84CX LogP: 2.29CX LogD: 2.28Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.56Np Likeness Score: -0.65
References 1. (2020) STK4 inhibitors for treatment of hematologic malignancies,